Delivery Order SPE2DB20D3101-SPE2DB25FRRX7
- Not listed
- The Defense Logistics Agency awarded a $1,129.62 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 4, 2025. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. Valtoco is a seizure rescue medication delivered via nasal spray, supporting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a ceiling value of $1,558.12 and a firm fixed price structure. The delivery order, issued on August 1, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This award was not subject to any set-aside designation and was...
- The Defense Logistics Agency awarded a delivery order valued at $1,372.92 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 1, 2025. This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $2,309.22 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of July 28, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded on July 26, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays. This firm fixed price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, was awarded without a set-aside designation through competitive procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Valtoco 10 mg nasal sprays, with a contract ceiling value of $2,259.24 and an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Valtoco is a...
- The Defense Logistics Agency awarded a delivery order valued at $7,935.13 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The award utilizes no set-aside designation, consistent with the company's demonstrated capability to compete openly for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Valtoco 10 mg nasal sprays, with a contract ceiling value of $1,203.35. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,141.96 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal spray on July 29, 2025, with a completion date of July 30, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a nasal spray formulation used for acute seizure management, reflecting the breadth of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Valtoco 10 mg nasal spray, a seizure rescue medication. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,784.67 and is scheduled for completion by August 4, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRRX7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays, valued at $1,160.56 with a firm fixed price arrangement. This non-set-aside contract was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. Valtoco is a seizure rescue medication delivered via nasal spray, reflecting AmerisourceBergen's role as a critical pharmaceutical distributor for federal military and healthcare systems. As a major pharmaceutical and healthcare solutions provider, AmerisourceBergen regularly fulfills federal medical procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The company's extensive contract portfolio with the DLA Medical Supply Chain demonstrates its capability to meet federal procurement standards through competitive award processes, supporting healthcare delivery to military personnel and veterans through the Defense Health Agency and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/5/25 |